BioPharma Pharma QC

Cherwell reaches custom cleanroom product development milestone in its 50th year

 Cherwell Laboratories, specialists in cleanroom microbiology solutions, announces in its 50th anniversary year that it has successfully develope...

 June 29, 2021 | News

SP launches SP Hull LyoStar(R) 4.0 to enhance speed to market in drug development

New advanced pilot-scale lyophilizer supports rapid and highly effective freezedry cycle development, optimization and process scale-up   Based on a...

 June 23, 2021 | News

Innovent Biologics Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medi...

 June 22, 2021 | News

MSD Announces Supply Agreement with U.S. Govt. for Molnupiravir

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it has entered into a procurement agreement with&...

 June 21, 2021 | News

Novo Nordisk Plans Global Expansion With Amalgam Rx

Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform...

 June 17, 2021 | News

Avantor® Completes Acquisition of Ritter GmbH and its Affiliates

By combining Ritter's liquid dispensing platform for clinical diagnostic testing and life sciences research with Avantor's offerings for critical lab autom...

 June 12, 2021 | News

Innovative Mass Spectrometer Designed for Small Molecule Analysis

Small molecule researchers in academia, pharmaceutical, and biopharmaceutical industries can now use a new, intelligent mass spectrometer (MS) to reveal co...

 June 08, 2021 | News

Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX™

ASCO 2021, which celebrates its 57th anniversary this year, runs from June 4th to June 8th and will be held virtually due to COVID-19. Some ...

 June 07, 2021 | News

Liminal BioSciences Update Clinical Activities for Fezagepras

Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today that bas...

 May 31, 2021 | News

PerkinElmer to acquire Nexcelom Bioscience for $260 Million in cash.

 PerkinElmer, Inc. (NYSE: PKI) is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million&...

 May 17, 2021 | News

Advancing gene therapy by solving challenges in scale-up & manufacturing

Dr. Brophy shares additional insight about how producing viral vectors can be made more efficient, the lessons that can be learned from manufacturing mAbs ...

 May 11, 2021 | Influencers


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close